Karen E Hoffman

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi request reprint The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial
    Karen E Hoffman
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX, 77030, USA
    Qual Life Res 23:1841-58. 2014
  2. ncbi request reprint Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial
    Karen E Hoffman
    Departments of Radiation Oncology and Radiation Physics, The University of Texas, MD Anderson Cancer Center, Houston, Texas Electronic address
    Int J Radiat Oncol Biol Phys 88:1074-84. 2014
  3. pmc Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Hermann Pressler Drive, Unit 1484, Houston, TX 77030, USA
    Breast Cancer Res 14:R83. 2012
  4. doi request reprint Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Semin Radiat Oncol 22:284-94. 2012
  5. ncbi request reprint Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy
    Karen E Hoffman
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 13:e270-6. 2012
  6. doi request reprint Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 185:116-20. 2011
  7. doi request reprint Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 183:1798-802. 2010
  8. pmc Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness
    Karen E Hoffman
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Cancer 118:248-57. 2012
  9. ncbi request reprint Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer
    Arti Parekh
    Department of Radiation Oncology, Dana Farber Brigham and Women s Hospital, Harvard Medical School, Boston, MA
    Brachytherapy 12:415-21. 2013
  10. doi request reprint Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone
    Arti Parekh
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Urology 81:130-4. 2013

Detail Information

Publications55

  1. ncbi request reprint The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial
    Karen E Hoffman
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX, 77030, USA
    Qual Life Res 23:1841-58. 2014
    ..The Radiation Therapy Oncology Group (RTOG) conducted a randomized, placebo-controlled trial evaluating the efficacy of GM-CSF in reducing mucosal injury and symptom burden from curative radiotherapy for head and neck (H&N) cancer...
  2. ncbi request reprint Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial
    Karen E Hoffman
    Departments of Radiation Oncology and Radiation Physics, The University of Texas, MD Anderson Cancer Center, Houston, Texas Electronic address
    Int J Radiat Oncol Biol Phys 88:1074-84. 2014
    ....
  3. pmc Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1400 Hermann Pressler Drive, Unit 1484, Houston, TX 77030, USA
    Breast Cancer Res 14:R83. 2012
    ....
  4. doi request reprint Management of older men with clinically localized prostate cancer: the significance of advanced age and comorbidity
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Semin Radiat Oncol 22:284-94. 2012
    ..Prostate cancer management decisions for older patients should be tailored based on an individual patient's health status, coexisting medical conditions, life expectancy, and tumor characteristics...
  5. ncbi request reprint Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy
    Karen E Hoffman
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Lancet Oncol 13:e270-6. 2012
    ..Randomised clinical trial data are needed to assess whether postmastectomy radiation therapy can be safely omitted in selected women with good response to neoadjuvant chemotherapy...
  6. doi request reprint Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 185:116-20. 2011
    ....
  7. doi request reprint Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    J Urol 183:1798-802. 2010
    ..In this study we evaluated the influence of health status and life expectancy on prostate specific antigen screening in older men in the United States before the 2008 United States Preventive Services Task Force guidelines...
  8. pmc Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness
    Karen E Hoffman
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Cancer 118:248-57. 2012
    ..A study was undertaken to determine the survival benefit of postoperative chemoradiation therapy for elderly patients with resected gastric adenocarcinoma...
  9. ncbi request reprint Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer
    Arti Parekh
    Department of Radiation Oncology, Dana Farber Brigham and Women s Hospital, Harvard Medical School, Boston, MA
    Brachytherapy 12:415-21. 2013
    ..To determine which specific comorbidities predispose men to excess mortality by androgen deprivation therapy (ADT) given before and during brachytherapy for prostate cancer...
  10. doi request reprint Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone
    Arti Parekh
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Urology 81:130-4. 2013
    ..To report the relative incidence of the perceived reduction in penile size across prostate cancer treatment modalities and to describe its effect on quality of life and treatment regret...
  11. ncbi request reprint Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period
    Ayal A Aizer
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts
    Cancer 120:1532-9. 2014
    ..In the current study, the authors assessed whether racial disparities in cancer-specific mortality have improved over the last 20 years...
  12. ncbi request reprint Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women
    Shervin M Shirvani
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
    Cancer 117:4595-605. 2011
    ..Accordingly, the authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare cohort to determine whether the use of PMRT has increased in response to evidence-based guidelines...
  13. doi request reprint Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?
    Michelle M Kim
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard Unit 97, Houston, TX 77030 4009, USA
    Eur J Cancer 48:1664-71. 2012
    ....
  14. ncbi request reprint Cancer-specific outcomes among young adults without health insurance
    Ayal A Aizer
    Ayal A Aizer and Benjamin Falit, Harvard Radiation Oncology Program Mallika L Mendu and Quoc Dien Trinh, Brigham and Women s Hospital Toni K Choueiri, Neil E Martin, Brian M Alexander, and Paul L Nguyen, Brigham and Women s Hospital Dana Farber Cancer Institute Boston, MA Ming Hui Chen, University of Connecticut, Storrs, CT Karen E Hoffman, University of Texas MD Anderson Cancer Center, Houston, TX and Jim C Hu, University of California Los Angeles, Los Angeles, CA
    J Clin Oncol 32:2025-30. 2014
    ..We examined the association between insurance status and cancer-specific outcomes among young adults...
  15. doi request reprint Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02215, USA
    Int J Radiat Oncol Biol Phys 82:1411-6. 2012
    ....
  16. ncbi request reprint Outcomes in stage I testicular seminoma: a population-based study of 9193 patients
    Clair J Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer 119:2771-7. 2013
    ..In particular, data describing long-term risks of cardiovascular disease (CVD) are conflicting...
  17. doi request reprint Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?
    Katherine O Castle
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 85:693-9. 2013
    ....
  18. ncbi request reprint Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy
    David C Weksberg
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 20:3430-7. 2013
    ..We characterize the clinical course and predictive features of salvage treatment for LRR after breast conserving therapy (BCT) analyzed by initial treatment...
  19. ncbi request reprint Improvement in prostate cancer survival over time: a 20-year analysis
    Michelle M Kim
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009 USA
    Cancer J 18:1-8. 2012
    ..This study aimed to evaluate the changes in outcome for men with localized prostate cancer treated with definitive external beam radiation therapy during a 20-year period at a comprehensive cancer center...
  20. pmc Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation
    Grace L Smith
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Int J Radiat Oncol Biol Phys 88:274-84. 2014
    ..Recently proposed "suitability" criteria guiding patient selection for brachytherapy have never been empirically validated...
  21. pmc PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era
    Sean E McGuire
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Int J Radiat Oncol Biol Phys 85:e39-46. 2013
    ....
  22. doi request reprint Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    BJU Int 110:201-5. 2012
    ....
  23. doi request reprint Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 79:1318-22. 2011
    ..Brachytherapy for prostate cancer can be technically challenging in men with small prostates (≤20 cc), but it is unknown whether their outcomes are different than those of men with larger prostates...
  24. doi request reprint Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Cancer 116:610-5. 2010
    ..Therefore, our ability to determine who would benefit from salvage hormonotherapy (HT) would be enhanced if an individual's risk of nonprostate-cancer-specific mortality were known...
  25. doi request reprint Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era
    Paul L Nguyen
    Harvard Radiation Oncology Program, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 74:104-9. 2009
    ..We examined the accuracy of this formula in contemporary patients...
  26. ncbi request reprint Marital status and survival in patients with cancer
    Ayal A Aizer
    Ayal A Aizer, Harvard Radiation Oncology Program Ellen P McCarthy, Beth Israel Deaconess Medical Center Mallika L Mendu, Sophia Koo, Powell L Graham, Neil E Martin, and Paul L Nguyen, Dana Farber Brigham and Women s Cancer Center Tyler J Wilhite, Harvard Medical School, Boston, MA Ming Hui Chen, University of Connecticut, Storrs, CT Karen E Hoffman, The University of Texas MD Anderson Cancer Center, Houston, TX and Jim C Hu, University of California at Los Angeles, Los Angeles, CA
    J Clin Oncol 31:3869-76. 2013
    ..To examine the impact of marital status on stage at diagnosis, use of definitive therapy, and cancer-specific mortality among each of the 10 leading causes of cancer-related death in the United States...
  27. doi request reprint Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy
    Thomas J Pugh
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Brachytherapy 12:204-9. 2013
    ..To determine the ability of endorectal magnetic resonance imaging (erMRI) and other pretreatment factors to predict the presence and extent of extraprostatic extension (EPE) in men with Gleason score (GS) 7 prostate cancer...
  28. ncbi request reprint Is primary prostate cancer treatment influenced by likelihood of extraprostatic disease? A surveillance, epidemiology and end results patterns of care study
    Jordan A Holmes
    Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
    Int J Radiat Oncol Biol Phys 84:88-94. 2012
    ..To examine the patterns of primary treatment in a recent population-based cohort of prostate cancer patients, stratified by the likelihood of extraprostatic cancer as predicted by disease characteristics available at diagnosis...
  29. ncbi request reprint Barriers to the implementation of surveillance for stage I testicular seminoma
    Nils D Arvold
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Int J Radiat Oncol Biol Phys 84:383-9. 2012
    ..Because studies suggest that radiation oncologists in the United States continue to recommend RT for these patients, we sought to identify factors associated with management recommendations...
  30. doi request reprint Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    JAMA 306:2359-66. 2011
    ....
  31. doi request reprint Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study
    Raymond H Mak
    Harvard Radiation Oncology Program, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 80:978-84. 2011
    ..We evaluated the use of preoperative RT after the presentation of the landmark German rectal study results and examined the impact of tumor and sociodemographic factors on receiving preoperative RT...
  32. doi request reprint Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 78:1081-5. 2010
    ..2 GyE) or high-dose (79.2 GyE) radiation for prostate cancer...
  33. pmc Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer
    Thomas J Pugh
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas
    Int J Radiat Oncol Biol Phys 87:946-53. 2013
    ..To report quality of life (QOL)/toxicity in men treated with proton beam therapy for localized prostate cancer and to compare outcomes between passively scattered proton therapy (PSPT) and spot-scanning proton therapy (SSPT)...
  34. pmc Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial
    CHELSEA PINNIX
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
    Int J Radiat Oncol Biol Phys 83:1089-94. 2012
    ..To determine the efficacy of an emulsion containing hyaluronic acid to reduce the development of ≥ Grade 2 radiation dermatitis after adjuvant breast radiation compared with best supportive care...
  35. doi request reprint Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy
    Deborah A Ahove
    Smith College, Northhampton, Massachusetts, USA
    Urology 76:1201-5. 2010
    ..To determine the predictors of late prostate-specific antigen (PSA) failure among men with an undetectable PSA level 5 years after radical prostatectomy (RP)...
  36. pmc Cost implications of the rapid adoption of newer technologies for treating prostate cancer
    Paul L Nguyen
    Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    J Clin Oncol 29:1517-24. 2011
    ..We assessed temporal trends in their utilization and their impact on national health care spending...
  37. ncbi request reprint Radiation therapy modalities in prostate cancer
    Thomas J Pugh
    From the Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA
    J Natl Compr Canc Netw 11:414-21. 2013
    ..This article reviews technologic advances that have enhanced radiation delivery and describes contemporary radiation treatment techniques for prostate cancer...
  38. doi request reprint Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy
    Catherine L Akay
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 19:901-7. 2012
    ..The current study was undertaken to evaluate this prognostic index in an independent cohort...
  39. pmc Influence of year of diagnosis, patient age, and sociodemographic status on recommending adjuvant radiation treatment for stage I testicular seminoma
    Karen E Hoffman
    Department of Radiation Oncology, Brigham and Women s Hospital, 375 Longwood Ave, Boston, MA 02115, USA
    J Clin Oncol 26:3937-42. 2008
    ..This study evaluated ART trends in the United States and the impact of clinical and sociodemographic factors on ART recommendations...
  40. ncbi request reprint Cardiac motion during deep-inspiration breath-hold: implications for breast cancer radiotherapy
    Xiaochun Wang
    Department of Radiation Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 82:708-14. 2012
    ..We measured the displacement of the left anterior descending artery (LAD) and heart owing to cardiac motion during DIBH, relative to the standard tangential fields for left breast cancer radiotherapy...
  41. ncbi request reprint Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer
    Karen E Hoffman
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Cancer 116:2590-5. 2010
    ..The authors of this report compared the use of brachytherapy alone with combined brachytherapy, external-beam radiation to the prostate and seminal vesicles, and androgen-suppression therapy (CMT) in this population...
  42. doi request reprint Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy
    Hadley J Sharp
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Pract Radiat Oncol 2:e7-e13. 2012
    ....
  43. pmc External-beam accelerated partial breast irradiation using multiple proton beam configurations
    Xiaochun Wang
    Department of Radiation Physics, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 80:1464-72. 2011
    ....
  44. ncbi request reprint Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla
    Dhara M Macdermed
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Pract Radiat Oncol 4:116-22. 2014
    ..The purpose of this study was to quantify radiation dose delivered to the axilla for patients treated in the prone position...
  45. pmc Practice-based evidence to evidence-based practice: building the National Radiation Oncology Registry
    Jason A Efstathiou
    Massachusetts General Hospital, Department of Radiation Oncology, Boston, MA 02114 2606, USA
    J Oncol Pract 9:e90-5. 2013
    ..The NROR pilot study will provide the framework for expansion to a nationwide electronic registry for radiation oncology. ..
  46. doi request reprint Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients
    Abigail S Caudle
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg Oncol 21:60-5. 2014
    ..The goal of this study was to identify characteristics associated with positive IM sentinel lymph nodes (SLNs) and the impact on adjuvant treatment...
  47. pmc Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery
    Jeffrey M Albert
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 30:2837-43. 2012
    ..However, it is not known whether this recommendation should extend to other older women. Accordingly, we developed a nomogram to predict the likelihood of long-term breast preservation with and without RT...
  48. doi request reprint Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control
    Jeffrey M Albert
    Department of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Breast Cancer Res Treat 128:421-7. 2011
    ..Historically inferior LRC with AC chemotherapy alone versus AC + T may have been due to an inadequate duration of systemic therapy and not due to the absence of paclitaxel...
  49. ncbi request reprint Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic
    Lydia T Madsen
    From the Departments of Genitourinary Medical Oncology, Radiation Oncology, Urology, and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas
    J Natl Compr Canc Netw 12:993-8. 2014
    ..Clinical trial enrollment in the MPCC was substantially higher than that seen nationally in adult patients with cancer, and enrollment rates increased after the introduction of a clinical trial initiative...
  50. ncbi request reprint Quantification of beam complexity in intensity-modulated radiation therapy treatment plans
    Weiliang Du
    Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030
    Med Phys 41:021716. 2014
    ..In this study, The authors have sought to develop metrics to characterize different aspects of beam complexity and investigate the beam complexity for IMRT plans of different disease sites...
  51. ncbi request reprint Psychological distress in long-term survivors of adult-onset cancer: results from a national survey
    Karen E Hoffman
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Arch Intern Med 169:1274-81. 2009
    ..As advances in cancer screening and treatment increase the number of long-term cancer survivors, it is important to understand the long-term psychological sequelae of the cancer experience...
  52. ncbi request reprint External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis
    Karen E Hoffman
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 112:943-9. 2008
    ..The effect of this incidental exposure on subsequent prostate cancer diagnosis was investigated using the Surveillance, Epidemiology, and End Results (SEER) cancer registry...
  53. doi request reprint Management of prostate cancer in elderly men
    Shelly X Bian
    Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    Semin Radiat Oncol 23:198-205. 2013
    ..Management decisions should be individualized by weighing the benefits of treatment against potential risks and side effects pertinent to the elderly population, whether evaluating for surgery, radiation, or androgen deprivation...
  54. pmc Emergence of integrated urology-radiation oncology practices in the State of Texas
    Pavan M Jhaveri
    Section of Radiation Oncology, Department of Radiology, Baylor College of Medicine, Houston, Texas, USA
    Int J Radiat Oncol Biol Phys 84:15-9. 2012
    ..We sought to characterize the emergence of such practices in Texas, their extent of physical integration, and their potential effect on patient travel times for radiation therapy...
  55. ncbi request reprint Radiation therapy for pediatric central nervous system tumors
    Karen E Hoffman
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    J Child Neurol 24:1387-96. 2009
    ..The long-term clinical benefits of proton radiation in the pediatric population are just beginning to be reported in the literature...